← All Sponsors
SPONSOR

Cedars-Sinai Medical Center

Total Trials
12
Recruiting
12
Phases
Phase 2, Phase 1, Phase 2

Cedars-Sinai Medical Center is a clinical research sponsor with 12 registered studies on ClinicalTrials.gov, of which 12 are actively recruiting participants. Research covers conditions including Shoulder Disease, Shoulder Injuries, Heart Disease, Stress Urinary Incontinence.

The trial portfolio spans Phase 2, Phase 1, Phase 2 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.

Frequently Asked Questions — Cedars-Sinai Medical Center

How many clinical trials has Cedars-Sinai Medical Center sponsored?
ClinicalMetric currently tracks 12 clinical trials sponsored by Cedars-Sinai Medical Center, of which 12 are actively recruiting participants. These trials cover conditions including Shoulder Disease, Shoulder Injuries, Heart Disease. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Cedars-Sinai Medical Center research focus on?
Cedars-Sinai Medical Center clinical trials span Shoulder Disease, Shoulder Injuries, Heart Disease, Stress Urinary Incontinence, Idiopathic Pulmonary Fibrosis, and additional conditions. The research pipeline includes Phase 2, Phase 1, Phase 2 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Cedars-Sinai Medical Center clinical trial?
To participate in a Cedars-Sinai Medical Center trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Cedars-Sinai Medical Center trials with current recruitment status updated daily.

Clinical Trials by Cedars-Sinai Medical Center

NCT06016257
Recruiting

Using VirtuaCareTM Platform for Home Programs in Acute and Chronic Shoulder Conditions: A Pilot Study

Shoulder Disease
NCT00573027
Recruiting

Heart Disease of the Small Arteries in Women and Men

Heart Disease
NCT02316275
Recruiting

Impact of Unrestrictive Exercise Following Mid-Urethral Sling Surgery

Stress Urinary Incontinence
NCT06567717 Phase 2
Recruiting

Zinc and Nicotinamide Riboside for Idiopathic Pulmonary Fibrosis

Idiopathic Pulmonary Fibrosis
NCT07605715
Recruiting

Transcatheter vs. Surgical Treatment of Degenerative Mitral Regurgitation

Degenerative Mitral Valve Disease
NCT02609685
Recruiting

Active Surveillance of Papillary Thyroid Microcarcinoma

Papillary Thyroid Microcarcinoma
NCT07017673 Phase 2
Recruiting

Phase II Trial of Ivonescimab in Combination With Carboplatin + Docetaxel in Patients With Early-Stage Triple Negative Breast Cancer

TNBC
NCT06856694
Recruiting

RCT of NLP-Based Feedback for Improving SDM in Men With Localized Prostate Cancer

Prostate Cancer
NCT03193515
Recruiting

A Novel Multiplex ELISA Assay for Surveilling Patients With History of Bladder Cancer

Bladder Cancer
NCT04224558 Phase 1, Phase 2
Recruiting

Stem Cell Transplantation in Crohn's Disease

Crohn Disease
NCT07413965
Recruiting

TAVR vs SAVR in Severe Bicuspid Aortic Stenosis

Bicuspid Aortic Valve Disease
NCT04722341
Recruiting

Time-Restricted Eating and Cancer: Clinical Outcomes, Mechanisms, and Moderators

Colorectal Cancer
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology